Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study to Compare the Effect of Treatment With Carbidopa/Levodopa/Entacapone on the Quality of Life of Patients With Parkinson's Disease.

NCT00143026 is registered in ClinicalTrials.gov with Novartis as lead sponsor.

NCT NCT00143026
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00143026 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study to Compare the Effect of Treatment With Carbidopa/Levodopa/Entacapone on the Quality of Life of Patients With Parkinson's Disease.
Lead sponsor
Novartis
Phase
Phase 4
Overall status
Completed
Start date
July 31, 2005
Completion date
June 30, 2006
Enrollment
184 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson's disease